![]() |
|
|
Forward to a colleague |
||
Access Full Stories A long-acting injectable formulation of Eli Lilly's blockbuster schizophrenia treatment Zyprexa (olanzapine), with the potential to improve patient adherence and take some of the sting out of generic competition... Read Teva sprints ahead of the API field With active pharmaceutical ingredient sales of $1,460m (€960.8m) in 2007 and a portfolio of more than 250 compounds, Teva Pharmaceutical Industries is by a long stretch the dominant supplier in the global... Read BASF hikes prices on intermediates, hydrosulfites German chemicals giant BASF has announced its latest brace of price rises, this time for two forms of carboxylic acid and for bleaching and reducing agents... Read GSK's UK plant to lose out to outsourcing A UK chemicals plant has become the latest casualty of GlaxoSmithKline's (GSK's) pledge to make the business leaner with the help of outsourcing and offshoring... Read NIH to lighten up heavy peer review process Researchers applying to the US National Institutes of Health (NIH) for research grants could find the complicated peer-review process easier to navigate in the future under new proposals designed to revamp the... Read |
||||||||||||||||||
All News Headlines for: March | February | January |
||||||||||||||||||
![]() Comprehensive Solutions for Highly Potent API Supply Experienced in a wide variety of highly potent APIs supply, ScinoPharm has the full breadth capabilities to deliver the highly potent API services from innovative chemistry solutions to cGMP API manufacture for both clinical trial and commercial production... Click Here | ||||||||||||||||||
|
Related Industry News Big pharma to persist with external reliance Big pharma's thirst for external innovation is set to persist amidst the blockbuster drought... Read China tells drug importers to take responsibility for quality China's drug watchdog has revealed its stance on drug exports from the country: the bottom line is buyer beware... Read European MIT rival to be operating by 2009 The prospect of Europe's very own institute of technology - dubbed the European equivalent of MIT - is looking increasingly likely... Read Covance triumphant in animal lab battle Covance has emerged triumphant in the latest episode of a long-lasting saga over a new US animal testing lab that it is building in Chandler, Arizona... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2008 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||